Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden (Q30402040)

21 June 2017

title

Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden (English)

1 reference

21 June 2017

0 references

0 references

Ingela Berggren

2

0 references

Birgitta de Jong Skierus

series ordinal

4

object named as

Birgitta de Jong

1 reference

21 June 2017

Ake Ortqvist

1

1 reference

21 June 2017

Mona Insulander

series ordinal

3

1 reference

21 June 2017

Bo Svenungsson

series ordinal

5

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

Clinical Infectious Diseases

21 June 2017

published in

1 reference

21 June 2017

volume

52

1 reference

21 June 2017

issue

10

1 reference

21 June 2017

page(s)

1203-1211

1 reference

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

21 June 2017

cites work

1 reference

Response to a monovalent 2009 influenza A (H1N1) vaccine.

21 January 2018

1 reference

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

21 January 2018

1 reference

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

21 January 2018

1 reference

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

21 January 2018

1 reference

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

21 January 2018

1 reference

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

21 January 2018

1 reference

Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.

21 January 2018

1 reference

Protective effect of single-dose adjuvanted pandemic influenza vaccine in children

21 January 2018

1 reference

Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study

21 January 2018

1 reference

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

21 January 2018

1 reference

Safety and Effectiveness of a 2009 H1N1 Vaccine in Beijing

21 January 2018

1 reference

Development and implementation of a molecular diagnostic platform for daily rapid detection of 15 respiratory viruses.

21 January 2018

1 reference

The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong

21 January 2018

1 reference

Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic

21 January 2018

1 reference

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter

21 January 2018

1 reference

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

21 January 2018

1 reference

Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections

21 January 2018

1 reference

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1093/CID/CIR182

1 reference

21 June 2017

1 reference